Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL
Clinical trial NCT04491721 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04491721
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-01
- Primary completion
- 2027-06-01
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.